TAROPHEN 36 MG

Država: Izrael

Jezik: angleščina

Source: Ministry of Health

Kupite ga zdaj

Prenos Navodilo za uporabo (PIL)
08-08-2023

Aktivna sestavina:

METHYLPHENIDATE HYDROCHLORIDE

Dostopno od:

TARO INTERNATIONAL LTD, ISRAEL

Koda artikla:

N06BA04

Farmacevtska oblika:

TABLETS EXTENDED RELEASE

Sestava:

METHYLPHENIDATE HYDROCHLORIDE 36 MG

Pot uporabe:

PER OS

Tip zastaranja:

Required

Izdeluje:

SUN PHARMACEUTICAL INDUSTRIES, INC,USA

Terapevtsko območje:

METHYLPHENIDATE

Terapevtske indikacije:

Treatment of Attention Deficit Hyperactivity Disorder (ADHD)

Datum dovoljenje:

2023-05-08

Navodilo za uporabo

                                Patient leaflet in accordance with the Pharmacists' Regulations
(Preparations) – 1986
This medicine is dispensed with a doctor’s prescription only
Tarophen 18 mg
Tarophen 27 mg
Tarophen 36 mg
Tarophen 54 mg
Extended-release tablets
Active ingredient
Each Tarophen 18 mg tablet contains 18 mg methylphenidate
hydrochloride.
Each Tarophen 27 mg tablet contains 27 mg methylphenidate
hydrochloride.
Each Tarophen 36 mg tablet contains 36 mg methylphenidate
hydrochloride.
Each Tarophen 54 mg tablet contains 54 mg methylphenidate
hydrochloride.
Inactive ingredients and allergens in this medicine: see section 6
‘Additional
information’.
Read the entire leaflet carefully before you start using this
medicine.
This leaflet contains concise information about this medicine. If you
have any
further questions, consult your doctor or pharmacist.
This medicine has been prescribed for you. Do not pass it on to
others. It may
harm them, even if it seems to you that their medical condition is
similar to
yours.
1. What is this medicine intended for?
Tarophen is intended for the treatment of Attention Deficit
Hyperactivity
Disorder (ADHD) in children over the age of 6, adolescents, and adults
up to
the age of 65.
Therapeutic group: central nervous system stimulant.
Tarophen can improve attention and concentration, and reduce
impulsiveness
and hyperactivity in individuals with ADHD. Tarophen should be given
as part
of an ADHD treatment program that may include counseling or other
therapies.
2. Before using this medicine
Do not use this medicine if you or your child:
•
is sensitive (allergic) to the active ingredient (methylphenidate
hydrochloride) or to any of the other ingredients in this medicine
(see
section 6, ‘Additional information’).
•
is very anxious, mentally tense, or agitated (suffers from
restlessness)
•
has an eye problem called glaucoma (increased intraocular pressure)
•
has tics or Tourette's syndrome, or a family history of Tourette's
syndrome. Tics are involuntary repeated movements or sounds.
•
is 
                                
                                Preberite celoten dokument
                                
                            

Dokumenti v drugih jezikih

Navodilo za uporabo Navodilo za uporabo arabščina 08-08-2023
Navodilo za uporabo Navodilo za uporabo hebrejščina 08-08-2023

Opozorila o iskanju, povezana s tem izdelkom

Ogled zgodovine dokumentov